Tailoring mathematical models to specific iPSC-CM cell lines improves the accuracy of electrophysiological and drug-response predictions, highlighting the importance of accounting for inter-cell line variability in preclinical drug screening.
Answers are grounded in this paper and cite their sources.
Cell-line specific iPSC-CM models may refine disease modeling and drug screening; leaves open validation for adult CM translation.
Human induced pluripotent stem cell derived cardiomyocytes (iPSC-CMs) have applications in disease modeling, cell therapy, drug screening and personalized medicine. Computational models can be used to interpret experimental findings in iPSC-CMs, provide mechanistic insights, and translate these findings to adult cardiomyocyte (CM) electrophysiology. However, different cell lines display different expression of ion channels, pumps and receptors, and show differences in electrophysiology. In this exploratory study, we use a mathematical model based on iPSC-CMs from Cellular Dynamic International (CDI, iCell), and compare its predictions to novel experimental recordings made with the Axiogenesis Cor.4U line. We show that tailoring this model to the specific cell line, even using limited data and a relatively simple approach, leads to improved predictions of baseline behavior and response to drugs. This demonstrates the need and the feasibility to tailor models to individual cell lines, although a more refined approach will be needed to characterize individual currents, address differences in ion current kinetics, and further improve these results.
No takes yet. Share an insight, caveat, or question.
Lei et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: